baber/WOPTO huggingface dataset:
Patent DE-69031829-D1 (DE)
Inventor: MOTT JOHN R
IPC: C04B14/42
Filed: 1990-04-26
Granted: 1998-01-29
Abstract: A ladle is used in the manufacture of metals and for receiving molten metal for further chemical processing or for transportation. The ladle comprises a glass-cement outer shell (18), refractory linings (20,22) and trunnions (30). The ladle is transparent to a wide range of electromagnetic radiation wavelengths which allows the metal to be heated or stirred by induction without heating the ladle itself. As the ladle is made of glass fibre and an inorganic cement, strength is provided along with high temperature resistance. The ladle is manufactured by winding glass fibre around a mandrel, and incorporating an inorganic cement. The cement may be coated on the fibre as an aqueous slurry, and the product allowed to air cure after winding. Alternatively, the cement may be adhered to the fibre by electrostatic attraction. After winding is complete, additional cement may be added and the product placed in an autoclave supplied with steam whereby the cement takes up water; it is then allowed to cure. After curing, the moulding is preferably sawn in half to form two inductively transparent ladles.
Patent DE-69101505-D1 (DE)
Inventor: CARLSSON LENNART
IPC: A61C13/12
Filed: 1991-01-11
Granted: 1994-05-05
Abstract: Device made of a tissue-compatible material and intended to temporarily cover the so-called spacer (2) during a particular period of incorporation of a dental implant (1, 2), preferably in single-tooth replacement. The base section (12) of the device is designed in such a way that it guides the healing of the mucous membrane to assume a contour such that securing of the crown (5) is facilitated, and a certain possibility of controlling the seam (8) between the crown (5) and the spacer (2) is afforded. The device is preferably made of an elastic material for good clamp fitting on the spacer, as a result of which the use of paste, dental cement or the like is eliminated.
Patent DE-69104487-D1 (DE)
Inventor: RAYMOND JEAN-LOUIS
IPC: A61J9/04
Filed: 1991-07-19
Granted: 1994-11-10
Abstract: Device of the feeding-bottle type comprising: an external tubular body (1) having an open extremity (1b); a flexible capsule or container (3) housed or capable of being housed within said tubular body and presenting also an extremity (C) which is open or arranged to be opened; means (2, 42) allowing to communicate with environmental air, the space (D) existing between said flexible capsule (3) and the body (1); a specific teat (12) mounted or conformed to be mounted ahead of the openings (A, C) of said body (1) and said capsule (3); and an intermediary non-return valve (5) arranged between the open extremity (C) of said capsule (3) and the base of said teat (12) and delimiting with the latter a dispensing chamber (F); characterized in that a second valve (19, 20) is provided in the nipple piece (15) of the teat (12), between the dispensing chamber (F) and the outlet perforations (18) of said teat, said second valve (19-20) allowing the passage of nutrient liquid towards said outlet perforations (18) and opposing the entry of air into said dispensing chamber (F).
Patent DE-69107301-D1 (DE)
Inventor: CHELLE RENE
IPC: A01N43/90
Filed: 1991-07-23
Granted: 1995-03-23
Abstract: The invention relates to Theophylline, a human and veterinary therapeutic product, proposed as an ingestible poison for eliminating moles. It is added to baits consisting of earthworms, or to baits having a different composition. The ingestion of these baits causes the death of the mole in a few hours following symptoms which have strong analogies with the symptoms of intoxications which occur accidentally in man.
Patent DE-69109276-D1 (DE)
Inventor: LARUELLE CLAUDE
IPC: A61K8/00
Filed: 1991-02-13
Granted: 1995-06-01
Abstract: PCT No. PCT/FR91/00114 Sec. 371 Date Oct. 13, 1992 Sec. 102(e) Date Oct. 13, 1992 PCT Filed Feb. 13, 1991 PCT Pub. No. WO91/11996 PCT Pub. Date Aug. 22, 1991.Hydroquinone amino-acid esters having formula (I), pharmaceutical or cosmetic compositions containing them, particularly dermatological compositions having pigment-removing activity, and the pharmaceutical, cosmetic or aesthetic uses thereof. The preparation of these novel hydroquinone esters from natural amino-acid derivatives is also described.    <IMAGE>  (I)
Patent DE-69109811-D1 (DE)
Inventor: GRAAS MAURICE
IPC: B60C11/01
Filed: 1991-11-07
Granted: 1995-06-22
Abstract: A winter type tire tread (11) comprises an uneven number of, but at least three, circumferentially extending axially spaced grooves (4-6) and a plurality of zig-zag shaped grooves (36, 37) disposed circumferentially about the tire in a repetitive manner and extending across the tread from the equatorial plane (EP) towards the lateral edges (TE1, TE2) of the tire. The zig-zag shaped grooves (36, 37) situated on one side of the equatorial plane (EP) are symmetrical to those situated on the opposite side of the equatorial plane. The circumferentially and laterally extending grooves (4-6, 36, 37) define block elements (20-23), arranged in circumferentially extending rows (30-33) and having each at least in part the shape of a parallelogram. A plurality of sipes (15) are incorporated in each block element. <IMAGE>
Patent DE-69117284-D1 (DE)
Inventor: ADAIR JOHN ROBERT
IPC: C12N15/11
Filed: 1991-12-20
Granted: 1996-03-28
Abstract: Recombinant, in particular humanised, e.g. humanised chimeric and CDR-grafted humanised, antibody molecules having specificity for human TNF alpha , are provided for use in diagnosis and therapy. In particular the antibody molecules have antigen binding sites derived from murine monoclonal antibodies CB0006, CB010, hTNF3 or 101.4. Preferred CDR-grafted humanised anti-hTNF alpha  antibodies comprise variable region domains comprising human acceptor framework and donor antigen binding regions and wherein the frameworks comprise donor residues at specific positions. The antibody molecules may be used for therapeutic treatment of human patients suffering from or at risk of disorders associated with undesirably high levels of TNF, in particular for treatment of immunoregulatory and inflammatory disorders or of septic, endotoxic or cardiovascular shock. <IMAGE>
Patent DE-69118856-D1 (DE)
Inventor: SUZUKI SHIGERU
IPC: C03C10/06
Filed: 1991-12-19
Granted: 1996-05-23
Abstract: A processing method is presented for treating sludges from municipal and waste materials. The ashes from such sludges, containing SiO2 as a primary constituent, are treated with additives to tailor the feed material composition. Thermal processing, including melting, rapid cooling and subsequent annealing, produces a crystallized glass microstructure in which needle-shaped crystals of anorthite and  beta -wollastnite are infiltrated with a vitreous material. Such crystallized glasses having superior mechanical and aesthetic properties are an attractive architectural material which can be utilized for interior finishing, exterior walls, flooring as well as for interior decorations.
Patent DE-69126430-D1 (DE)
Inventor: GREENE MARK
IPC: A61K38/22
Filed: 1991-04-04
Granted: 1997-07-10
Abstract: PCT No. PCT/US91/02331 Sec. 371 Date Sep. 24, 1992 Sec. 102(e) Date Sep. 24, 1992 PCT Filed Apr. 4, 1991 PCT Pub. No. WO91/15230 PCT Pub. Date Oct. 17, 1991.A purified proteinaceous substance bindable with p185, the translation product of the neu oncogene is disclosed. The purified proteinaceous substance may be characterized in that it increases the activity of the tyrosine kinase contained in the neu oncogene product but does not increase the activity of tyrosine kinase of epidermal growth factor receptor; induces p185 dimerization and internalization; affects the growth of cells which express p185 in a dose dependent manner; is heat stable from about 56 DEG  C. to about 100 DEG  C.; is degradable by protease; and has a molecular weight of from about 7,000 to about 14,000 daltons in its smallest active form as determined by gel filtration and ultrafiltration membrane analysis. Methods of detecting p185 on the surfaces of tumor cells are also disclosed.
Patent DE-69132603-D1 (DE)
Inventor: GEURSEN HERMAN JOHAN
IPC: D06M101/00
Filed: 1991-10-17
Granted: 2001-06-13
Abstract: An aramid multifilament yarn, preferably poly(p-phenylene terephthalamide), is coated with a water swellable superabsorbent material. The swelling value of the yarn is at least 60. The superabsorbent provides water blocking capability to the yarn, so that it is suitable for use as a strength member in water tight optical communication cables. The yarn is made by successively treating an aramid yarn with a waterin-oil emulsion, a superabsorbent material being present in the water phase of the emulsion, and removing the liquid components from the treated yarn by evaporation.
Patent DE-69132772-D1 (DE)
Inventor: MUELLER RICHARD H
IPC: C07F5/02
Filed: 1991-04-16
Granted: 2001-11-22
Abstract: An improved process for preparation of compounds of the formula <CHEM> as disclosed. These compounds are useful as intermediates in the preparation of boronic acid adducts of technetium 99m dioxime complexes of the formula    <9><9><m>Tc X(Y)3Z   which are useful as imaging agents. o
Patent DE-69133158-D1 (DE)
Inventor: LARDY HENRY A
IPC: A61K/
Filed: 1991-08-28
Granted: 2003-01-02
Abstract: A method for controlling weight gain or promoting weight loss which includes the step of treating a subject with an effective weight gain controlling or weight loss promoting amount of a substituted (Delta)5-Androstene which is biologically effective for controlling weight gain or promoting weight loss and biologically ineffective for promoting the synthesis of sex hormones. Steroids believed to provide the desired weight control/weight loss characteristics include: (Delta)5-Androstene-3(beta),7(alpha)-diol-17-one (Delta)5-Androstene-3(beta)-ol-7,17-dione (Delta)5-Androstene-3(beta),7(alpha),17-triol (Delta)5-Androstene-3(beta),17(beta)-diol-7-one and various derivatives thereof.
Patent DE-69205302-D1 (DE)
Inventor: VAN DE SCHEE WILLEM EDUARD
IPC: A47B9/04
Filed: 1992-02-20
Granted: 1995-11-16
Abstract: The invention lies in the field of tables whereof the work surface is height-adjustable. The invention has for its object to provide a leg structure (1) which, using simple means, offers a greatly increased mechanical stability and a greatly improved load-taking capacity of the work surface (3) and provides a leg structure with adjustable length for bearing together with at least one other leg structure a work surface, which leg structure comprises: a foot (2) for placing on the ground; a support (4) for coupling to the work surface; two pillars of adjustable length which are rigidly connected on one side to the foot and on the other to the support, each of which pillars comprises: two parts telescopically movable relative to one another, namely an upper part that is connected to the support and a lower part connected to the foot and provided with a spindle nut into which is screwed a screw spindle mounted on the upper part; a right angle transmission present on the upper part wherein the right angle transmissions of both pillars have equal transmission ratios and are mutually coupled such that when the screw spindles are rotated the pillars undergo equal changes in length; and drive means for rotatably driving the screw spindles. <IMAGE>
Patent DE-69206276-D1 (DE)
Inventor: COOK STEVEN
IPC: C07C53/12
Filed: 1992-09-28
Granted: 1996-01-04
Abstract: Disclosed is an improved process for the removal of acetone from a production system wherein acetic anhydride is produced by contacting a mixture comprising methyl iodide and methyl acetate and/or dimethyl ether with carbon monoxide in the presence of a carbonylation catalyst or catalyst system. The process comprises two distillation steps wherein acetone is separated from a mixture of methyl acetate, methyl iodide and acetone.
Patent DE-69208885-D1 (DE)
Inventor: SMEDAL ARNE
IPC: B63B9/06
Filed: 1992-09-02
Granted: 1996-04-11
Abstract: PCT No. PCT/NO92/00139 Sec. 371 Date Jun. 28, 1994 Sec. 102(e) Date Jun. 28, 1994 PCT Filed Sep. 2, 1992 PCT Pub. No. WO93/04911 PCT Pub. Date Mar. 18, 1993.In a hull the skin plate is built up as a composite member with an outer skin, a core and an inner skin. The skin plate is placed on the framework which includes longitudinal stiffeners. The inner skin is constructed as a diaphragm element relative to the external water pressure, while the core is made as a pressure-absorbing element and the outer skin is constructed primarily as a bending stressed element. The inner skin as a diaphragm will take tensile stress and be protected against outer local stresses. The material in the core can be chosen without major requirements to be able to tolerate shearing stress. The outer skin can be dimensioned and made primarily to take local shock loads.
Patent DE-69213500-D1 (DE)
Inventor: MORI SHOSEI
IPC: G02F1/13
Filed: 1992-02-13
Granted: 1996-10-17
Abstract: A liquid crystal composition, comprising: at least one mesomorphic compound represented by the following formula (I): <CHEM> wherein R<1> and R<2> independently denote a linear or branched alkyl group having 1 - 18 carbon atoms capable of including one or non-neighboring two or more methylene groups which can be replaced with at least one species of -O-, -CO-, -COO-, -OCO-, -OCOO- or -CH(X)- with the proviso that -O- cannot directly be connected to -O- and X denotes halogen; Z<1> denotes -COO- or -CH2O-; X<1> and X<2> independently denote a single bond, -O-, -COO-, -OCO-, -CO- or -OCOO-; A<1> denotes a single bond, <CHEM> Y<1> and Y<2> independently denote hydrogen, halogen, -CH3- or CF3-; and at least one mesomorphic compound represented by the following formula (II):    R<3>-X<3>-A<2>-B-A<3>-X<4>-R<4>   (II),   wherein R<3> and R<4> independently denote a linear or branched alkyl group having 1 - 18 carbon atoms capable of including one or non-neighboring two or more methylene groups which can be replaced with at least one species of -O-, -CO-, -COO-, -OCO-, -OCOO- or -CH(X)- with the proviso that -O- cannot directly be connected to -O- and X denotes halogen; X<3> and X<4> independently denotes a single bond, -O-, -COO-, -OCO- or -CO-; B denotes <CHEM>  A<2> denotes a single bond, <CHEM> A<3> denotes a single bond, -A<4>- or -A<4>-A<5>- wherein A<4> and A<5> independently denote A<2>, <CHEM> and Y<3> and Y<4> independently denote hydrogen, F, Cl, Br, -CH3, -CN or -CF3. The liquid crystal composition is easily aligned by a simple rubbing method to provide a uniform monodomain and further provides wider driving voltage and temperature margins effective for providing a practical ferroelectric liquid crystal device. <IMAGE>
Patent DE-69215009-D1 (DE)
Inventor: BLUM PATRICIA RAE
IPC: B01J27/198
Filed: 1992-06-03
Granted: 1996-12-12
Abstract: Disclosed is a process for making acetic acid which comprises oxidizing ethane with molecular oxygen in a reaction zone at a pressure of at least 100 psig while the reactants are in contact with a solid catalyst having the elements and relative atomic proportions indicated by the empirical formula:    VPaMbOx    where M is one or more optional element selected from Co, Cu, Re, Fe, Ni, Nb, Cr, W, U, Ta, Ti, Zr, Zn, Hf, Mn, Pt, Pd, Sn, Sb, Bi, Ce, As, Ag, and Au,  wherein     a is 0.5 to 3,     b is 0 to 1, and x is a number determined by the valence requirements of the other elements in the catalyst,  and wherein said catalyst contains crystalline vanadyl pyrophosphate.
Patent DE-69218098-D1 (DE)
Inventor: VAN DER TOL JOHANNES JACOBUS G
IPC: G02B6/34
Filed: 1992-09-01
Granted: 1997-04-17
Abstract: The invention provides a wavelength division multiplexer and a wavelength division demultiplexer by combining a wavelength-selective mode converter (3) with a wavelength-independent mode splitter (5). The demultiplexer comprises a monomodal input channel (1), an adapter (2) to the bimodal input of a 100%TX<4><4>TTY<4><5>(g<5>) mode converter (3), a bimodal junction channel (4), and a mode splitter (5) having a first output channel (6) and a second output channel (7), both monomodal, the first output channel (6) having a higher propagation constant than the second. A g<5> component, which propagates with a polarisation TX (TE or TM) in an input signal Si1(g<5>,g<6>,g<7>,--), will, after conversion in the converter (3), propagate in the intermediate channel (4), in the first-order guided mode having the polarisation TY (TE or TM), and subsequently leave the splitter via output channel (7). The remainder of the input signal is not affected by the converter, therefore remains in the zero-order mode in the intermediate channel (4), and will leave the splitter (5) via output channel (6). The multiplexer operates in the opposite direction. Advantages: Completely producible in integrated form, no fabrication steps of a different type required other than for the fabrication of the connecting optical waveguides. <IMAGE>
Patent DE-69218583-D1 (DE)
Inventor: HILL MARK LANGDON
IPC: E05B17/20
Filed: 1992-09-14
Granted: 1997-04-30
Abstract: An improved automobile handle guard plate assembly which provides added strength via a lipped brace (3) which overlays and strengthens a security plate (4). The security plate (4) and the brace (3) are secured together with an adhesive and positioned between the exterior door handle and the automobile's door. The door handle is permitted easy access to the locking mechanism within the door via an opening in the security plate (4). A thief trying to enter the automobile by accessing the locking mechanism through the door, finds a security plate (4) to prevent access and a brace (3) on the security plate (4) for preventing deformation of the security plate (4).
Patent DE-69224521-D1 (DE)
Inventor: HAKE LAWRENCE W
IPC: A61M5/32
Filed: 1992-05-22
Granted: 1998-04-02
Abstract: A needle guard and a method to prevent needle stick injuries are disclosed, for use with a hypodermic syringe or other instrument with a sharp point. The needle guard, comprises a protective sleeve with a fitting, that may be used with or added to a conventional syringe and needle assembly. The interior of the fitting contains a deformable engagement means adapted to permanently engage the fitting on the syringe barrel. Prior to and during use of the needle, the sleeve remains in a retracted position covering the barrel of the syringe. After the needle has been used, the sleeve is pushed forward into its locked extended position, so that the end of the sleeve extends beyond the tip of the needle. The tip of the needle is thereby shielded, preventing accidental sticks.
Patent DE-69226772-D1 (DE)
Inventor: LANTERO ORESTE
IPC: C12N9/30
Filed: 1992-05-15
Granted: 1998-10-01
Abstract: The invention relates to a process for producing ethanol from raw materials, that contain fermentable sugars or constituents which can be converted into sugars, comprising the steps of: a-liquefaction of the raw materials in the presence of an alpha-amylase for obtaining liquefied mash, b-saccharification of the liquefied mash in the presence of a glucoamylase for obtaining hydrolyzed starch and sugars, c-fermentation of the hydrolyzed starch and sugars by yeast for obtaining ethanol, and d-recovering alcohol, a protease being introduced in the liquefied mash during the saccharification and/or in the hydrolyzed starch and sugars during the fermentation. The invention relates also to a composition containing a glucoamylase and an acid fungal protease.
Patent DE-69228436-D1 (DE)
Inventor: TSUJI TETSUO
IPC: C12N15/09
Filed: 1992-11-12
Granted: 1999-03-25
Abstract: A hybridoma producing a monoclonal antibody recognizing the C-terminus of human brain natriuretic peptide (hBNP) was cultivated in a medium or the abdominal cavity of a mouse to recover the monoclonal antibody from the medium or ascites accumulated in the abdominal cavity. An immunoassay of hBNP was established using the monoclonal antibody. The immunoassay of hBNP of this invention is so sensitive that the minimum detection limit is 1 pg/ml and can therefore determine an hBNP level in blood plasma directly, that is, without the extraction of hBNP from blood plasma. It is useful for diagnosing diseases such as hypertension and the like and states of heart, kidney and the like with taking an increase/decrease of an hBNP level as an index.
Patent DE-69233466-D1 (DE)
Inventor: MURAKAMI TOKUMICHI
IPC: H04N19/132
Filed: 1992-10-21
Granted: 2005-02-03
Abstract: For performing high-efficient coding, a coding system comprises:(a) input means for inputting an input signal (201) to be encoded;(b) a field memory (28, 29) for storing the input signal by dividing said signal into a plurality of fields such as the odd field and even field;(c) predictive signal output means for outputting a plurality of predictive signals predicting the change of input signal corresponded to each signal stored in said field memory;(d) a selector (21) for selecting a predictive signal from the predictive signals provided by said predictive signal output means; and(e) coding means (24) for encoding the input signal using the relationship between said predictive signal selected by said selector and the input signal from said input means.
Patent DE-69305080-D1 (DE)
Inventor: GRIFFITHS BRYAN
IPC: A61K9/70
Filed: 1993-06-28
Granted: 1996-10-31
Abstract: PCT No. PCT/GB93/01350 Sec. 371 Date Nov. 22, 1994 Sec. 102(e) Date Nov. 22, 1994 PCT Filed Jun. 28, 1993 PCT Pub. No. WO94/00164 PCT Pub. Date Jan. 6, 1994An alginate fibre is provided which includes one or more medicaments incorporated into the fibre core such that the one or more medicaments can be released in a sustained manner over time and, optionally, one or more medicaments attached to the surface of the fibre whereby the one or more medicaments attached to the surface of the fibre can be released rapidly therefrom.
Patent DE-69314478-D1 (DE)
Inventor: BAJUSZ SANDOR
IPC: C07K5/06
Filed: 1993-03-04
Granted: 1997-11-13
Abstract: PCT No. PCT/HU93/00013 Sec. 371 Date Dec. 5, 1994 Sec. 102(e) Date Dec. 5, 1994 PCT Filed Mar. 4, 1993 PCT Pub. No. WO93/18060 PCT Pub. Date Sep. 16, 1993This invention relates to new peptide derivatives of the general formula (I) A-Xaa-Arg-H, wherein A represents a D- or L-isochroman-1-carbonyl, D- or L-isochroman-3-carbonyl group, furthermore an acyl group of the general formula: D- or DL-A'-CH(OH)-CO, wherein A' represents a phenyl, benzyl, 1-naphthyl, 1-naphthylmethyl, 2-naphthyl, 2-naphthylmethyl, 9-fluorenyl, benzhydryl, cyclohexyl, cyclohexylmethyl, 2-pyridyl, 3-pyridyl or 4-pyridyl group, and Xaa represents an L-prolyl or an L-pipecolinic acid residue, and Arg stands for an L-arginine residue, their acid addition salts formed with an organic or inorganic acid and pharmaceutical compositions containing the same. Furthermore the invention relates to a process for preparing them. The compounds of the invention have valuable therapeutic, particularly anticoagulant, properties.
Patent DE-69316085-D1 (DE)
Inventor: LINDER CHARLES DR
IPC: G01N27/447
Filed: 1993-05-21
Granted: 1998-02-12
Abstract: Immobilized buffered gels obtained from hydroxy group containing natural or synthetic polymers and acid or basic di- or triazine derivatives are useful and highly effective media, e.g. in form of membranes, for preparative isoelectric focusing electrophoresis for separating high molecular compounds, such as proteins or peptides, from biological mixtures.